Back
Halozyme Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
HALO
Halozyme Therapeutics
Last Price:
47.79
Seasonality Move:
17.34%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.13 | Buy |
| 20-day SMA: | 52.96 | Sell |
| 50-day SMA: | 54.19 | Sell |
| 200-day SMA: | 49.33 | Sell |
| 8-day EMA: | 48.36 | Sell |
| 20-day EMA: | 50.94 | Sell |
| 50-day EMA: | 53.37 | Sell |
| 200-day EMA: | 50.43 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.26 | Sell |
| Relative Strength Index (14 RSI): | 41.07 | Sell |
| Chaikin Money Flow: | 837944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.59 - 58.19) | Sell |
| Bollinger Bands (100): | (51.1 - 60.64) | Sell |
Halozyme Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 47.79 while HALO 8-day simple moving average is 46.13, which is a Buy signal.
- The stock price of HALO is 47.79 while Halozyme Therapeutics 20-day SMA is 52.96, which makes it a Sell.
- Halozyme Therapeutics 50-day simple moving average is 54.19 while HALO share price is 47.79, making it a Sell technically.
- HALO stock price is 47.79 and Halozyme Therapeutics 200-day simple moving average is 49.33, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
53
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a Buy
The current Halozyme Therapeutics [HALO] share price is $47.79. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6.08B
Price in USD:
47.79
Share Volume:
1.4M
Halozyme Therapeutics 52-Week Range
52-Week High:
65.53
52-Week Low:
33.15
Buy
53
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?
The Halozyme Therapeutics stock price is 47.79 USD today. -
Will HALO stock go up or go down?
Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Halozyme Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 47.79 while HALO 8-day exponential moving average is 48.36, which is a Sell signal.
- The stock price of HALO is 47.79 while Halozyme Therapeutics 20-day EMA is 50.94, which makes it a Sell.
- Halozyme Therapeutics 50-day exponential moving average is 53.37 while HALO share price is 47.79, making it a Sell technically.
- HALO stock price is 47.79 and Halozyme Therapeutics 200-day simple moving average is 50.43, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
- HALO Moving Average Covergence Divergence (MACD) indicator is -2.26, suggesting Halozyme Therapeutics is a Sell
- Halozyme Therapeutics Relative Strength Index (RSI) is 41.07, which suggest Halozyme Therapeutics is oversold
- The Bollinger Bands (25) for Halozyme Therapeutics is (46.59 - 58.19), which suggest Halozyme Therapeutics is a Sell
- The Bollinger Bands (100) for Halozyme Therapeutics is (51.1 - 60.64), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.